News und Analysen

CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending December 31, 2023 in respect of the CI ETFs. In all cases, the distribution

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today that, in connection with the Corporation’s ongoing substantial issuer bid (the “Offer”), the Ontario Securities

CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $420.7 billion as at October 31, 2023, consisting of asset management assets of $117.1 billion, Canadian wealth

Today, Glory announces the latest solution in its new GLR series of Teller Cash Recyclers (TCRs), the GLR-200. Building upon the successful launch of GLR-100 in August last year (read press release

Today, Glory announces the latest solution in its new GLR series of Teller Cash Recyclers (TCRs), the GLR-200. Building upon the successful launch of GLR-100 in August last year (read press release

Today, Glory announces the latest solution in its new GLR series of Teller Cash Recyclers (TCRs), the GLR-200. Building upon the successful launch of GLR-100 in August last year (read press release

CI Global Asset Management (“CI GAM”) announces the estimated annual reinvested capital gains distributions (the “Reinvested Distributions”) for the 2023 tax year for the CI ETFs listed below.

CI Global Asset Management (“CI GAM”) announces that it has updated its Responsible Investing Policy (“Policy”) in accordance with guidance from staff of the Ontario Securities Commission on

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2667 per stapled unit for the month of

CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending November 30, 2023 in respect of the CI ETFs. In all cases, the distribution will be

CI Global Asset Management (“CI GAM”) announces that its investment funds have been recognized with 19 LSEG Lipper Fund Awards for 2023. The awards identify mutual funds and exchange-traded funds

CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has commenced its previously announced substantial issuer bid (the “Offer”), pursuant to which the Corporation

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous

CI Financial Corp. (“CI”) (TSX: CIX) today released financial results for the quarter ended September 30, 2023.

“The benefits of CI’s ongoing strategic transformation are demonstrated in our

Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three and nine month periods ended

CI Global Asset Management (“CI GAM”) today announced the launch of new series of CI Emerging Markets Bond Fund (the “Fund”), providing individual investors with expanded access to this distinct

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous

Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2023.

Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering for the optimization of combustion systems, emissions control and water treatment in utility and industrial

Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous

ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world's only recombinant